Detalhe da pesquisa
1.
Onco-nephrology: Physicians' Expectations About a New Subspecialty.
J Cancer Educ
; 38(3): 878-884, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840858
2.
[Electrolyte disorders in oncological patients]. / Principaux troubles hydro-électrolytiques chez le patient de cancérologie.
Bull Cancer
; 2023 May 17.
Artigo
em Francês
| MEDLINE | ID: mdl-37208250
3.
A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma.
Anticancer Res
; 43(10): 4723-4727, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772584
4.
[Sodium thiosulfate in preventing ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic solid tumors]. / Le thiosulfate de sodium en prévention de l'ototoxicité induite par le cisplatine dans la population pédiatrique ayant une tumeur solide localisée.
Bull Cancer
; 111(2): 129-130, 2024 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-38092636
5.
[New drug approval: Lenvatinib plus pembrolizumab for advanced renal cell carcinoma]. / Nouvelle AMM : association lenvatinib et pembrolizumab en première ligne du carcinome rénal à cellules claires avancé.
Bull Cancer
; 109(7-8): 737-738, 2022.
Artigo
em Francês
| MEDLINE | ID: mdl-35599170
6.
[Drug approval: Olaparib - metastatic castration-resistant prostate cancer with BRCA mutation]. / Olaparib cancer de prostate métastatique résistant à la castration muté BRCA.
Bull Cancer
; 108(2): 140-142, 2021 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-33546874